~~<i id='607D7DCAFE'><strike id='607D7DCAFE'><tt id='607D7DCAFE'><pre id='607D7DCAFE'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：focus 2025-10-06 09:53:41 Page View：848

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Humans aren't the only ones with an imagination. Rats have it too
Next article： Medical records are filled with copy

explore

Medical leaders decry Supreme Court decision on affirmative action

STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

Explaining an after

AdobeThisarticlewasadaptedfromSTAT’slatestreport,“Subgroupanalysis:howtoevaluateposthoctestsforsigni

George Santos makes 1st court appearance after pleading not guilty to 13 counts

1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

The health care issue Democrats can’t solve: hospital reform

MikeReddyforSTATWASHINGTON—Democratsunilaterallydrovemajorreformstothehealthinsuranceandthepharmaceu